Table 7 Effect of fungal infection on patients’ outcomes
Total case (n = 253) | Negative Fungal (n = 170) | Positive Fungal (n = 83) | Candidiasis (n = 61) | Aspergillosis (n = 11) | Mucormycosis (n = 5) | Other fungi (n = 6) | |||
|---|---|---|---|---|---|---|---|---|---|
Blood | Sputum | Urine | Multisite infection | ||||||
Noninvasive MV (n = 135) | 67/170 (39.4%) | 68/83 (81.9%) | 5/6 (83.3%) | 15/20 (75%) | 12/17 (70.6%) | 17/18 (94.4%) | 9/11 (81.8%) | 5/5 (100%) | 5/6 (83.3%) |
Invasive MV (n = 79) | 24/170 (14.1%) | 55/83 (66.2%) | 5/6 (83.3%) | 8/20 (40%) | 7/17 (41.2%) | 16/18 (88.9%) | 9/11 (81.8%) | 5/5 (100%) | 5/6 (83.3%) |
Length of hospital stay: median (range) | 6.9 (2–24) | 13.5 (2–47) | 11.9 (7–25) | 14.1 (2–47) | 15.5 (4–21) | 13.4 (3–25) | 13.6 (7–20) | 17.6 (14–20) | 12.7 (2–19) |
Case fatality (n = 75/253) (29.6%) | 22/170 (12.9%) | 53/83 (63.9%) | 5/6 (83.3%) | 7/20 35% | 6/17 (35.3%) | 16/18 (88.9%) | 9/11 (81.8%) | 5/5 (100%) | 5/6 (83.3%) |